Last reviewed · How we verify
Matched-Placebo for Primaquine — Competitive Intelligence Brief
phase 3
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Matched-Placebo for Primaquine (Matched-Placebo for Primaquine) — GlaxoSmithKline. This is a placebo control formulation matched to primaquine, an antimalarial drug that eliminates dormant liver-stage parasites and gametocytes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Matched-Placebo for Primaquine TARGET | Matched-Placebo for Primaquine | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Matched-Placebo for Primaquine CI watch — RSS
- Matched-Placebo for Primaquine CI watch — Atom
- Matched-Placebo for Primaquine CI watch — JSON
- Matched-Placebo for Primaquine alone — RSS
Cite this brief
Drug Landscape (2026). Matched-Placebo for Primaquine — Competitive Intelligence Brief. https://druglandscape.com/ci/matched-placebo-for-primaquine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab